A cancer-specific activatable theranostic nanodrug for enhanced therapeutic efficacy via amplification of oxidative stress

Rationale: Despite considerable advances, the reactive oxygen species (ROS)-mediated cancer treatment suffers from the problems of up-regulation of adaptive antioxidants in cancer cells as well as side effects to normal cells. Therefore, development of a new generation of cancer-specific nanomedicin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xie-an, Lu, Mi, Luo, Yingping, Hu, Yiting, Zhang, Ying, Xu, Zhiming, Gong, Shuaishuai, Wu, Yunhao, Ma, Xiao-Nan, Yu, Bo-Yang, Tian, Jiangwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929611/
https://www.ncbi.nlm.nih.gov/pubmed/31903126
http://dx.doi.org/10.7150/thno.39412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929611/
https://www.ncbi.nlm.nih.gov/pubmed/31903126
http://dx.doi.org/10.7150/thno.39412

Ejemplares similares